港股开盘：恒指涨0.47%、科指涨0.38%，科网股、石油股及券商股活跃，生物医药概念股回调

Market Overview - The Hong Kong stock market opened higher on January 9, with the Hang Seng Index rising by 0.47% to 26,272.54 points, the Hang Seng Tech Index increasing by 0.38% to 5,699.97 points, the State-Owned Enterprises Index up by 0.35% to 9,070.91 points, and the Red Chip Index gaining 0.45% to 4,112.86 points [1] - Major technology stocks saw positive movement, with Alibaba up 3.79%, JD Group up 3.31%, and Bilibili up 2.95%. However, Meituan and Kuaishou experienced declines of 0.99% and 0.90%, respectively [1] - Oil stocks generally rose, with PetroChina increasing by over 1%. Chinese brokerage stocks were active, with Dongfang Securities rising by nearly 1% [1] - The biopharmaceutical sector saw a pullback, with BeiGene down over 3% [1] - Three new stocks were listed today, all opening higher: Reborn Bio-B surged over 29%, MINIMAX soared over 42%, and Jinxun Resources rose over 26% [1] Company News - Fast Retailing (06288.HK) reported first-quarter earnings for the period ending November 30, 2025, with revenue of 1,027.745 billion yen, a year-on-year increase of 14.8%, and net profit of 147.445 billion yen, up 11.7% year-on-year [2] - Vanke Enterprises (02202.HK) announced that Yu Liang has resigned from his positions as director and executive vice president due to retirement [3] - Baolong Real Estate (01238.HK) projected a total contract sales amount of approximately 7.272 billion yuan for 2025, a year-on-year decrease of 43.13% [4] - China General Nuclear Power (01816.HK) expects a total on-grid electricity of approximately 2,326.48 billion kilowatt-hours for 2025, a year-on-year increase of 2.36% [4] - Meirui Health International (02327.HK) plans to acquire 100% equity of Jiangsu Yide for 125 million yuan [5] Strategic Developments - CWT International (00521.HK) has formalized a memorandum of cooperation with SF Express Singapore to jointly build a one-stop local and international logistics service [6] - Dimy Life Holdings (01667.HK) has entered into a strategic cooperation framework agreement with partners to venture into the electronic vaporization industry [7] - Xianjian Technology (01302) received formal registration approval from the National Medical Products Administration for its G-iliacTM Pro iliac artery stent system [8] Stock Buybacks - Tencent Holdings (00700.HK) repurchased 1.034 million shares for 636 million HKD at prices ranging from 610.5 to 618.5 HKD [8] - Xiaomi Group (01810.HK) repurchased 5 million shares for 191 million HKD at prices between 38.04 and 38.16 HKD [9] - Bairong Cloud (06608.HK) repurchased 415,000 shares for 51.783 million HKD at prices between 12.41 and 12.51 HKD [10] - Juzhi Biotechnology (02367.HK) repurchased 40,000 shares for 13.7106 million HKD at prices between 34.12 and 34.44 HKD [11] Institutional Insights - Everbright Securities suggests that domestic policy initiatives combined with a weaker US dollar may lead to continued upward movement in the Hong Kong stock market, highlighting strong overall profitability and relatively low valuations [12] - Dongwu Securities anticipates significant catalysts for the commercial aerospace industry in 2026, particularly with the launch of multiple reusable and large-capacity commercial rockets [12] - Kaiyuan Securities notes a "dual-drive" investment logic in semiconductor materials and equipment, driven by supply chain security concerns and recent capital investments in domestic manufacturing [12]